Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
TC

Thomas Chittenden — 20 Patents

IMImmunogen: 17 patents #15 of 119Top 15%
ATApoptosis Technology: 3 patents #1 of 9Top 15%
Sudbury, MA: #74 of 857 inventorsTop 9%
Massachusetts: #5,700 of 88,656 inventorsTop 7%
Overall (All Time): #214,803 of 4,157,543Top 6%
20 Patents All Time
Thomas Chittenden has been granted 20 US patents while listed as an inventor at Immunogen. The first was granted in 1997 and the most recent in February 2024. Thomas Chittenden ranks #214,803 of 4,157,543 US inventors in our database (top 5.2%). Patent records list Thomas Chittenden in Sudbury, MA, US.

Issued Patents All Time

Showing 1–20 of 20 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11897961 Anti-CD123 antibodies and conjugates and derivatives thereof Yelena Kovtun, Daniel Tavares, Lingyun Rui 2024-02-13
11834498 Biparatopic FR-alpha antibodies and immunoconjugates Olga AB, Neeraj Kohli, Julianto Setiady 2023-12-05 $160,137,000
11396543 Biparatopic FR-α antibodies and immunoconjugates Olga AB, Neeraj Kohli, Julianto Setiady 2022-07-26 $8,809,000
11332535 Anti-CD123 antibodies and conjugates and derivatives thereof Yelena Kovtun, Daniel Tavares, Lingyun Rui 2022-05-17 $11,741,000
10919969 Anti-CD123 antibodies and conjugates and derivatives thereof Yelena Kovtun, Daniel Tavares, Lingyun Rui 2021-02-16 $36,430,000
10875925 Anti-CD123 antibodies and conjugates and derivatives thereof Yelena Kovtun, Daniel Tavares, Lingyun Rui 2020-12-29 $23,606,000
10442865 Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof Yelena Kovtun, Daniel Tavares, Lingyun Rui 2019-10-15 $3,951,000
10077313 Anti-CD123 antibodies and conjugates and derivatives thereof Yelena Kovtun, Daniel Tavares, Lingyun Rui 2018-09-18 $20,031,000
9238690 Non-antagonistic EGFR-binding molecules and immunoconjugates thereof Julianto Setiady, Rajeeva Singh, Peter U. Park, Lingyun Rui 2016-01-19 $19,139,000
9233171 Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate Julianto Setiady, Peter U. Park 2016-01-12 $19,654,000
9125896 EGFR-binding molecules and immunoconjugates thereof Julianto Setiady, Peter U. Park, Lingyun Rui, Gillian Payne 2015-09-08 $28,613,000
8790649 EGFR-binding molecules and immunoconjugates thereof Julianto Setiady, Peter U. Park, Lingyun Rui, Gillian Payne 2014-07-29 $11,205,000
7358088 Peptides and compositions which modulate apoptosis Robert J. Lutz 2008-04-15 $1,870,000
7202346 Antibodies to non-shed Muc1 and Muc16, and uses thereof Gillian Payne, Viktor S. Goldmakher, Philip Chun, Kristin Sneider-Mulready, Carol A. Vater 2007-04-10 $1,277,000
7202024 bbc3 Gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter Jia-Wen Han 2007-04-10 $1,277,000
7097982 Peptides and compositions which modulate apoptosis Robert J. Lutz 2006-08-29 $1,668,000
6221615 Peptides and compositions which modulate apoptosis Robert J. Lutz 2001-04-24
5863795 Nucleic acids that encode peptides which modulate apoptosis Robert J. Lutz 1999-01-26
5672686 Bcl-Y - specific antibodies 1997-09-30 $579,000
5656725 Peptides and compositions which modulate apoptosis Robert J. Lutz 1997-08-12